277 related articles for article (PubMed ID: 30217058)
1. Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal Adenocarcinoma.
Dhayat SA; Traeger MM; Rehkaemper J; Stroese AJ; Steinestel K; Wardelmann E; Kabar I; Senninger N
Cancers (Basel); 2018 Sep; 10(9):. PubMed ID: 30217058
[TBL] [Abstract][Full Text] [Related]
2. Potential of Exosomal microRNA-200b as Liquid Biopsy Marker in Pancreatic Ductal Adenocarcinoma.
Reese M; Flammang I; Yang Z; Dhayat SA
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31941049
[TBL] [Abstract][Full Text] [Related]
3. The ambiguous role of microRNA-205 and its clinical potential in pancreatic ductal adenocarcinoma.
Michael Traeger M; Rehkaemper J; Ullerich H; Steinestel K; Wardelmann E; Senninger N; Abdallah Dhayat S
J Cancer Res Clin Oncol; 2018 Dec; 144(12):2419-2431. PubMed ID: 30244390
[TBL] [Abstract][Full Text] [Related]
4. Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma.
Flammang I; Reese M; Yang Z; Eble JA; Dhayat SA
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32630552
[TBL] [Abstract][Full Text] [Related]
5. Circulating microRNA-99 family as liquid biopsy marker in pancreatic adenocarcinoma.
Stroese AJ; Ullerich H; Koehler G; Raetzel V; Senninger N; Dhayat SA
J Cancer Res Clin Oncol; 2018 Dec; 144(12):2377-2390. PubMed ID: 30225540
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of circulating LAPTM4B-35 in pancreatic ductal adenocarcinoma.
Yang Z; Senninger N; Flammang I; Ye Q; Dhayat SA
J Cancer Res Clin Oncol; 2019 May; 145(5):1165-1178. PubMed ID: 30778748
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-100 and microRNA-21 as markers of survival and chemotherapy response in pancreatic ductal adenocarcinoma UICC stage II.
Dhayat SA; Abdeen B; Köhler G; Senninger N; Haier J; Mardin WA
Clin Epigenetics; 2015; 7():132. PubMed ID: 26705427
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.
Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H
Oncotarget; 2016 Mar; 7(13):16923-35. PubMed ID: 26943577
[TBL] [Abstract][Full Text] [Related]
9. The microRNA-200 family--a potential diagnostic marker in hepatocellular carcinoma?
Dhayat SA; Mardin WA; Köhler G; Bahde R; Vowinkel T; Wolters H; Senninger N; Haier J; Mees ST
J Surg Oncol; 2014 Sep; 110(4):430-8. PubMed ID: 24895326
[TBL] [Abstract][Full Text] [Related]
10. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.
Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A
Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644
[TBL] [Abstract][Full Text] [Related]
11. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-200c as a Prognostic Biomarker for Pancreatic Cancer.
Paik WH; Song BJ; Kim HW; Kim HR; Hwang JH
Korean J Gastroenterol; 2015 Oct; 66(4):215-20. PubMed ID: 26493507
[TBL] [Abstract][Full Text] [Related]
13. Expression of Epithelial-Mesenchymal Transition Markers in Treated Pancreatic Ductal Adenocarcinoma.
Wang M; Estrella JS; Katz MH; Kim M; Rashid A; Lee JE; Maitra A; Wistuba II; Wolff RA; Varadhachary GR; Wang H
Pancreas; 2019; 48(10):1367-1372. PubMed ID: 31688603
[TBL] [Abstract][Full Text] [Related]
14. WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC.
Pan Y; Lu F; Xiong P; Pan M; Zhang Z; Lin X; Pan M; Huang H
J Exp Clin Cancer Res; 2018 Jul; 37(1):167. PubMed ID: 30041660
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of miR-200 family microRNAs and epithelial-mesenchymal transition markers in oral squamous cell carcinoma.
Arunkumar G; Deva Magendhra Rao AK; Manikandan M; Prasanna Srinivasa Rao H; Subbiah S; Ilangovan R; Murugan AK; Munirajan AK
Oncol Lett; 2018 Jan; 15(1):649-657. PubMed ID: 29375721
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of Zinc finger E-box binding homeobox 1 (ZEB1) expression in cancer cells and cancer-associated fibroblasts in pancreatic head cancer.
Bronsert P; Kohler I; Timme S; Kiefer S; Werner M; Schilling O; Vashist Y; Makowiec F; Brabletz T; Hopt UT; Bausch D; Kulemann B; Keck T; Wellner UF
Surgery; 2014 Jul; 156(1):97-108. PubMed ID: 24929761
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ
Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230
[TBL] [Abstract][Full Text] [Related]
18. CD4
Goebel L; Grage-Griebenow E; Gorys A; Helm O; Genrich G; Lenk L; Wesch D; Ungefroren H; Freitag-Wolf S; Sipos B; Röcken C; Schäfer H; Sebens S
Oncoimmunology; 2015 Apr; 4(4):e1000083. PubMed ID: 26137395
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA 200b promotes mesenchymal-to-epithelial transition in anaplastic thyroid carcinoma.
Tamagawa S; Enomoto K; Gunduz E; Gunduz M; Sato F; Uchino S; Muragaki Y; Hotomi M
Oncol Lett; 2020 Oct; 20(4):3. PubMed ID: 32774477
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-200c overexpression plays an inhibitory role in human pancreatic cancer stem cells by regulating epithelial-mesenchymal transition.
Ma C; Ding YC; Yu W; Wang Q; Meng B; Huang T
Minerva Med; 2015 Aug; 106(4):193-202. PubMed ID: 26081037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
